NCT02192723View on ClinicalTrials.gov

A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Schizophrenia
Interventions
DRUG

Typical antipsychotic

Haloperidol (6\~20mg/day) and perphenazine (16\~64mg/day), twice per day, 8 weeks

DRUG

Risperidone

2\~6mg/day, twice per day, 8 weeks

DRUG

Olanzapine

Olanzapine, 400\~750mg/day, twice per day, 8 weeks

DRUG

Quetiapine

Quetiapine, 400～750mg/day, twice per day, 8 weeks

DEVICE

Aripiprazole

Aripiprazole, 10～30mg/day, twice per day, 8 weeks

DRUG

Ziprasidone

Ziprasidone 80\~160mg/day, twice per day, 8 weeks

Trial Locations (1)

100096

Beijing HuiLongGuan Hospital, Beijing

All Listed Sponsors
lead

Beijing HuiLongGuan Hospital

OTHER

NCT02192723 - A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia | Biotech Hunter | Biotech Hunter